Carole Phan

Paris, 75015, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Actin and myosin dynamics during epithelial remodeling in avian gastrulation.

Actin and myosin dynamics during epithelial remodeling in avian gastrulation.

Journal: Development (Cambridge, England)

Published: December 19, 2025

IDO-1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension.

IDO-1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension.

Journal: Journal of the American Heart Association

Published: August 12, 2025

Live imaging and functional characterization of the avian hypoblast redefine the mechanisms of primitive streak induction.

Live imaging and functional characterization of the avian hypoblast redefine the mechanisms of primitive streak induction.

Journal: Nature communications

Published: May 15, 2025

Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.

Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.

Journal: American journal of respiratory cell and molecular biology

Published: May 13, 2022

Self-organized tissue mechanics underlie embryonic regulation.

Self-organized tissue mechanics underlie embryonic regulation.

Journal: Nature

Published: March 31, 2022

Serum and pulmonary uric acid in pulmonary arterial hypertension.

Serum and pulmonary uric acid in pulmonary arterial hypertension.

Journal: The European respiratory journal

Published: February 15, 2020

Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.

Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.

Journal: Cardiovascular research

Published: April 09, 2019

Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease.

Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease.

Journal: The European respiratory journal

Published: January 24, 2019

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.

Journal: Circulation research

Published: January 15, 2019

Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.

Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: December 14, 2018

IL6R is the key therapeutical target in pulmonary arterial hypertension

IL6R is the key therapeutical target in pulmonary arterial hypertension

Journal: Medecine sciences : M/S

Published: November 20, 2018

Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.

Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.

Journal: Journal of medicinal chemistry

Published: March 13, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026